Abstract
Extracellular matrix (ECM) macromolecules, apart from structural role for the surrounding tissue, have also been defined as crucial mediators in several cell mechanisms. The proteolytic and cross-linking cascades of ECM have fundamental importance in health and disease, which is increasingly becoming acknowledged. However, formidable challenges remain to identify the diverse and novel role of ECM molecules, especially with regard to their distinct biophysical, biochemical, and structural properties. Considering the heterogeneous, dynamic, and hierarchical nature of ECM, the characterization of 3D functional molecular view of ECM in atomic detail will be very useful for further ECM-related studies. Nowadays, the creation of a pioneer ECM multidisciplinary integrated platform in order to decipher ECM homeostasis is more possible than ever. The access to cutting-edge technologies, such as optical imaging and electron and atomic force microscopies, along with diffraction and X-ray-based spectroscopic methods can integrate spanning wide ranges of spatial and time resolutions. Subsequently, ECM image-guided site-directed proteomics can reveal molecular compositions in defined native and reconstituted ECM microenvironments. In addition, the use of highly selective ECM enzyme inhibitors enables the comparative molecular analyses within pre-classified remodeled ECM microenvironments. Mechanistic information which will be derived can be used to develop novel protein-based inhibitors for effective diagnostic and/or therapeutic modalities targeting ECM reactions within tissue microenvironment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Theocharis AD, Karamanos NK (2017) Proteoglycans remodeling in cancer: underlying molecular mechanisms. Matrix Biol. https://doi.org/10.1016/j.matbio.2017.10.008
Karamanos NK, Passi A (2014) Novel insights into matrix pathobiology regulatory mechanisms in health and disease. FEBS J 281(22):4978–4979. https://doi.org/10.1111/febs.13106
Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3(12). https://doi.org/10.1101/cshperspect.a005058
Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8(3):221–233. https://doi.org/10.1038/nrm2125
Engler AJ, Humbert PO, Wehrle-Haller B, Weaver VM (2009) Multiscale modeling of form and function. Science 324(5924):208–212. https://doi.org/10.1126/science.1170107
Muschler J, Streuli CH (2010) Cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb Perspect Biol 2(10):a003202. https://doi.org/10.1101/cshperspect.a003202
Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 18(6):884–901. https://doi.org/10.1016/j.devcel.2010.05.012
Brix K, Dunkhorst A, Mayer K, Jordans S (2008) Cysteine cathepsins: cellular roadmap to different functions. Biochimie 90(2):194–207. https://doi.org/10.1016/j.biochi.2007.07.024
Adair-Kirk TL, Senior RM (2008) Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 40(6–7):1101–1110. https://doi.org/10.1016/j.biocel.2007.12.005
Crawford HC, Dempsey PJ, Brown G, Adam L, Moss ML (2009) ADAM10 as a therapeutic target for cancer and inflammation. Curr Pharm Des 15(20):2288–2299
Solomonov I, Zehorai E, Talmi-Frank D, Wolf SG, Shainskaya A, Zhuravlev A, Kartvelishvily E, Visse R, Levin Y, Kampf N, Jaitin DA, David E, Amit I, Nagase H, Sagi I (2016) Distinct biological events generated by ECM proteolysis by two homologous collagenases. Proc Natl Acad Sci U S A 113(39):10884–10889. https://doi.org/10.1073/pnas.1519676113
McGuire JK, Li Q, Parks WC (2003) Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am J Pathol 162(6):1831–1843. https://doi.org/10.1016/S0002-9440(10)64318-0
Zhang L, Rice AB, Adler K, Sannes P, Martin L, Gladwell W, Koo JS, Gray TE, Bonner JC (2001) Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts. Am J Respir Cell Mol Biol 24(2):123–131. https://doi.org/10.1165/ajrcmb.24.2.4096
Garcia-Prieto E, Gonzalez-Lopez A, Cabrera S, Astudillo A, Gutierrez-Fernandez A, Fanjul-Fernandez M, Batalla-Solis E, Puente XS, Fueyo A, Lopez-Otin C, Albaiceta GM (2010) Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One 5(10):e13242. https://doi.org/10.1371/journal.pone.0013242
Wu B, Crampton SP, Hughes CC (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26(2):227–239. https://doi.org/10.1016/j.immuni.2006.12.007
Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ (2006) A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 125(3):577–591. https://doi.org/10.1016/j.cell.2006.02.050
Wolf K, Alexander S, Schacht V, Coussens LM, von Andrian UH, van Rheenen J, Deryugina E, Friedl P (2009) Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 20(8):931–941. https://doi.org/10.1016/j.semcdb.2009.08.005
Overall CM, Kleifeld O (2006) Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6(3):227–239. https://doi.org/10.1038/nrc1821
Kruger A, Kates RE, Edwards DR (2010) Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition. Biochim Biophys Acta 1803(1):95–102. https://doi.org/10.1016/j.bbamcr.2009.09.016
Hu J, Van den Steen PE, Sang QX, Opdenakker G (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 6(6):480–498. https://doi.org/10.1038/nrd2308
Sela-Passwell N, Trahtenherts A, Kruger A, Sagi I (2011) New opportunities in drug design of metalloproteinase inhibitors: combination between structure-function experimental approaches and systems biology. Expert Opin Drug Discovery 6(5):527–542. https://doi.org/10.1517/17460441.2011.560936
Johnston KA, Lopez KM (2018) Lysyl oxidase in cancer inhibition and metastasis. Cancer Lett 417:174–181. https://doi.org/10.1016/j.canlet.2018.01.006
Li T, Wu C, Gao L, Qin F, Wei Q, Yuan J (2018) Lysyl oxidase family members in urological tumorigenesis and fibrosis. Oncotarget 9(28):20156–20164. https://doi.org/10.18632/oncotarget.24948
Cox TR, Gartland A, Erler JT (2016) Lysyl oxidase, a targetable secreted molecule involved in cancer metastasis. Cancer Res 76(2):188–192. https://doi.org/10.1158/0008-5472.CAN-15-2306
Wu L, Zhu Y (2015) The function and mechanisms of action of LOXL2 in cancer (Review). Int J Mol Med 36(5):1200–1204. https://doi.org/10.3892/ijmm.2015.2337
Contente S, Kenyon K, Rimoldi D, Friedman RM (1990) Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-ras. Science 249(4970):796–798
Cox TR, Erler JT (2013) Lysyl oxidase in colorectal cancer. Am J Physiol Gastrointest Liver Physiol 305(10):G659–G666. https://doi.org/10.1152/ajpgi.00425.2012
Erler JT, Giaccia AJ (2006) Lysyl oxidase mediates hypoxic control of metastasis. Cancer Res 66(21):10238–10241. https://doi.org/10.1158/0008-5472.CAN-06-3197
Liu SB, Ikenaga N, Peng ZW, Sverdlov DY, Greenstein A, Smith V, Schuppan D, Popov Y (2016) Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice. FASEB J 30(4):1599–1609. https://doi.org/10.1096/fj.14-268425
Ashley SL, Wilke CA, Kim KK, Moore BB (2017) Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis. Mucosal Immunol 10(2):341–351. https://doi.org/10.1038/mi.2016.61
Zhao W, Yang A, Chen W, Wang P, Liu T, Cong M, Xu A, Yan X, Jia J, You H (2018) Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking. Biochim Biophys Acta 1864(4 Pt A):1129–1137. https://doi.org/10.1016/j.bbadis.2018.01.019
Barker HE, Cox TR, Erler JT (2012) The rationale for targeting the LOX family in cancer. Nat Rev Cancer 12(8):540–552. https://doi.org/10.1038/nrc3319
Barker HE, Chang J, Cox TR, Lang G, Bird D, Nicolau M, Evans HR, Gartland A, Erler JT (2011) LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res 71(5):1561–1572. https://doi.org/10.1158/0008-5472.CAN-10-2868
Moreno-Bueno G, Salvador F, Martin A, Floristan A, Cuevas EP, Santos V, Montes A, Morales S, Castilla MA, Rojo-Sebastian A, Martinez A, Hardisson D, Csiszar K, Portillo F, Peinado H, Palacios J, Cano A (2011) Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol Med 3(9):528–544. https://doi.org/10.1002/emmm.201100156
Ikenaga N, Peng ZW, Vaid KA, Liu SB, Yoshida S, Sverdlov DY, Mikels-Vigdal A, Smith V, Schuppan D, Popov YV (2017) Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal. Gut 66(9):1697–1708. https://doi.org/10.1136/gutjnl-2016-312473
Kraft-Sheleg O, Zaffryar-Eilot S, Genin O, Yaseen W, Soueid-Baumgarten S, Kessler O, Smolkin T, Akiri G, Neufeld G, Cinnamon Y, Hasson P (2016) Localized LoxL3-dependent fibronectin oxidation regulates myofiber stretch and integrin-mediated adhesion. Dev Cell 36(5):550–561. https://doi.org/10.1016/j.devcel.2016.02.009
Gorogh T, Holtmeier C, Weise JB, Hoffmann M, Ambrosch P, Laudien M, Csiszar K (2008) Functional analysis of the 5′ flanking domain of the LOXL4 gene in head and neck squamous cell carcinoma cells. Int J Oncol 33(5):1091–1098
Afratis NA, Selman M, Pardo A, Sagi I (2018) Emerging insights into the role of matrix metalloproteases as therapeutic targets in fibrosis. Matrix Biol 68–69:167–179. https://doi.org/10.1016/j.matbio.2018.02.007
Afratis NA, Klepfish M, Karamanos NK, Sagi I (2018) The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: applications to drug discovery. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2018.03.004
Levin M, Udi Y, Solomonov I, Sagi I (2017) Next generation matrix metalloproteinase inhibitors - novel strategies bring new prospects. Biochim Biophys Acta 1864(11 Pt A):1927–1939. https://doi.org/10.1016/j.bbamcr.2017.06.009
Devel L, Czarny B, Beau F, Georgiadis D, Stura E, Dive V (2010) Third generation of matrix metalloprotease inhibitors: gain in selectivity by targeting the depth of the S1' cavity. Biochimie 92(11):1501–1508. https://doi.org/10.1016/j.biochi.2010.07.017
Glomski K, Monette S, Manova K, De Strooper B, Saftig P, Blobel CP (2011) Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures. Blood 118(4):1163–1174. https://doi.org/10.1182/blood-2011-04-348557
Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69(3):562–573. https://doi.org/10.1016/j.cardiores.2005.12.002
Lopez-Otin C, Palavalli LH, Samuels Y (2009) Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle 8(22):3657–3662. https://doi.org/10.4161/cc.8.22.9956
Doucet A, Overall CM (2008) Protease proteomics: revealing protease in vivo functions using systems biology approaches. Mol Asp Med 29(5):339–358. https://doi.org/10.1016/j.mam.2008.04.003
Aiken A, Khokha R (2010) Unraveling metalloproteinase function in skeletal biology and disease using genetically altered mice. Biochim Biophys Acta 1803(1):121–132. https://doi.org/10.1016/j.bbamcr.2009.07.002
Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P, American College of Gastroenterology IBDTF (2011) An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 106(Suppl 1):S2–S25; . quiz S26. https://doi.org/10.1038/ajg.2011.58
Jacobsen JA, Major Jourden JL, Miller MT, Cohen SM (2010) To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim Biophys Acta 1803(1):72–94. https://doi.org/10.1016/j.bbamcr.2009.08.006
Sela-Passwell N, Kikkeri R, Dym O, Rozenberg H, Margalit R, Arad-Yellin R, Eisenstein M, Brenner O, Shoham T, Danon T, Shanzer A, Sagi I (2011) Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential. Nat Med 18(1):143–147. https://doi.org/10.1038/nm.2582
Marshall DC, Lyman SK, McCauley S, Kovalenko M, Spangler R, Liu C, Lee M, O'Sullivan C, Barry-Hamilton V, Ghermazien H, Mikels-Vigdal A, Garcia CA, Jorgensen B, Velayo AC, Wang R, Adamkewicz JI, Smith V (2015) Selective allosteric inhibition of MMP9 is efficacious in preclinical models of ulcerative colitis and colorectal cancer. PLoS One 10(5):e0127063. https://doi.org/10.1371/journal.pone.0127063
Wong E, Cohen T, Romi E, Levin M, Peleg Y, Arad U, Yaron A, Milla ME, Sagi I (2016) Harnessing the natural inhibitory domain to control TNFalpha converting enzyme (TACE) activity in vivo. Sci Rep 6:35598. https://doi.org/10.1038/srep35598
Kefaloyianni E, Muthu ML, Kaeppler J, Sun X, Sabbisetti V, Chalaris A, Rose-John S, Wong E, Sagi I, Waikar SS, Rennke H, Humphreys BD, Bonventre JV, Herrlich A (2016) ADAM17 substrate release in proximal tubule drives kidney fibrosis. JCI Insight 1(13). https://doi.org/10.1172/jci.insight.87023
Zhang X, Wang Q, Wu J, Wang J, Shi Y, Liu M (2018) Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state. Proc Natl Acad Sci U S A 115(15):3828–3833. https://doi.org/10.1073/pnas.1720859115
Elbaum R, Tal E, Perets AI, Oron D, Ziskind D, Silberberg Y, Wagner HD (2007) Dentin micro-architecture using harmonic generation microscopy. J Dent 35(2):150–155. https://doi.org/10.1016/j.jdent.2006.07.007
Friedl P, Wolf K (2003) Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem Soc Symp 70:277–285
Gritsenko P, Leenders W, Friedl P (2017) Recapitulating in vivo-like plasticity of glioma cell invasion along blood vessels and in astrocyte-rich stroma. Histochem Cell Biol 148(4):395–406. https://doi.org/10.1007/s00418-017-1604-2
Friedl P, Brocker EB (2004) Reconstructing leukocyte migration in 3D extracellular matrix by time-lapse videomicroscopy and computer-assisted tracking. Methods Mol Biol 239:77–90
Dondossola E, Holzapfel BM, Alexander S, Filippini S, Hutmacher DW, Friedl P (2016) Examination of the foreign body response to biomaterials by nonlinear intravital microscopy. Nat Biomed Eng 1. https://doi.org/10.1038/s41551-016-0007
Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123(Pt 24):4195–4200. https://doi.org/10.1242/jcs.023820
Yu H, Mouw JK, Weaver VM (2011) Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol 21(1):47–56. https://doi.org/10.1016/j.tcb.2010.08.015
Grossman M, Born B, Heyden M, Tworowski D, Fields GB, Sagi I, Havenith M (2011) Correlated structural kinetics and retarded solvent dynamics at the metalloprotease active site. Nat Struct Mol Biol 18(10):1102–1108. https://doi.org/10.1038/nsmb.2120
Rosenblum G, Van den Steen PE, Cohen SR, Grossmann JG, Frenkel J, Sertchook R, Slack N, Strange RW, Opdenakker G, Sagi I (2007) Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B. Structure 15(10):1227–1236. https://doi.org/10.1016/j.str.2007.07.019
Rosenblum G, Meroueh S, Toth M, Fisher JF, Fridman R, Mobashery S, Sagi I (2007) Molecular structures and dynamics of the stepwise activation mechanism of a matrix metalloproteinase zymogen: challenging the cysteine switch dogma. J Am Chem Soc 129(44):13566–13574. https://doi.org/10.1021/ja073941l
Solomonov I, Talmi-Frank D, Milstein Y, Addadi S, Aloshin A, Sagi I (2014) Introduction of correlative light and air SEM microscopy imaging for tissue research under ambient conditions. Sci Rep 4:5987. https://doi.org/10.1038/srep05987
Porshinsky BS, Saha S, Grossman MD, Beery Ii PR, Stawicki SP (2011) Clinical uses of the medicinal leech: a practical review. J Postgrad Med 57(1):65–71. https://doi.org/10.4103/0022-3859.74297
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Afratis, N.A., Sagi, I. (2019). Novel Approaches for Extracellular Matrix Targeting in Disease Treatment. In: Vigetti, D., Theocharis, A.D. (eds) The Extracellular Matrix. Methods in Molecular Biology, vol 1952. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9133-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9133-4_21
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9132-7
Online ISBN: 978-1-4939-9133-4
eBook Packages: Springer Protocols